10/02/2024
10:16 AM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
1:44 PM | Acura Pharmaceuticals (Filer)
| Form NT 10-Q | |
07/26/2024
2:52 PM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
1:58 PM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
10:00 AM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:00 AM | Acura Pharmaceuticals (Filer)
| Form NT 10-Q | |
05/14/2024
3:40 PM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:00 AM | Acura Pharmaceuticals (Filer)
| Form NT 10-K | |
03/26/2024
12:06 PM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
9:53 AM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
9:27 AM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
4:13 PM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
2:20 PM | Acura Pharmaceuticals (Issuer)
WESSON BRUCE F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
2:20 PM | Acura Pharmaceuticals (Issuer)
THANGARAJ IMMANUEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
2:23 PM | Acura Pharmaceuticals (Issuer)
SKELLY WILLIAM G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
2:23 PM | Acura Pharmaceuticals (Issuer)
ROSS GEORGE K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
11:01 AM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
1:35 PM | Acura Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
11:07 AM | Acura Pharmaceuticals (Issuer)
Brzeczko Albert W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
11:07 AM | Acura Pharmaceuticals (Issuer)
CLEMENS PETER A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
11:08 AM | Acura Pharmaceuticals (Issuer)
Jones Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
11:08 AM | Acura Pharmaceuticals (Issuer)
Seiser Robert A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
